These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29196830)

  • 1. A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's Perspective.
    Chunyk AG; Joyce A; Fischer SK; Dysinger M; Mikulskis A; Jeromin A; Lawrence-Henderson R; Baker D; Yeung D
    AAPS J; 2017 Dec; 20(1):10. PubMed ID: 29196830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical challenges in development of ultrasensitive Home Brew assays: a case study using IL-13.
    Sperinde G; Hokom M; Peng K; Fischer SK
    Bioanalysis; 2019 Jun; 11(11):1045-1054. PubMed ID: 31251105
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.
    Poorbaugh J; Samanta T; Bright SW; Sissons SE; Chang CY; Oberoi P; MacDonald AJ; Martin AP; Cox KL; Benschop RJ
    J Immunol Methods; 2019 Mar; 466():9-16. PubMed ID: 30590020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of three platforms with ultrasensitive ligand-binding assay potential.
    Cowan KJ; Geiger A; Hornauer H; Rourick R; Siguenza PY
    Bioanalysis; 2017 Jun; 9(12):937-946. PubMed ID: 28627218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
    Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
    Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
    Yeung D; Ciotti S; Purushothama S; Gharakhani E; Kuesters G; Schlain B; Shen C; Donaldson D; Mikulskis A
    J Immunol Methods; 2016 Oct; 437():53-63. PubMed ID: 27555238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: implementation of automated Quanterix SIMOA instrumentation.
    Pleil JD; Angrish MM; Madden MC
    J Breath Res; 2015 Dec; 9(4):047108. PubMed ID: 26658359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Simoa Assay for Determination of Recombinant Batroxobin in Human Serum.
    Wang BZ; Wang MJ; Wang MR; Ou L; Dong LH; Dong K; Song HF
    Curr Med Sci; 2021 Jun; 41(3):618-625. PubMed ID: 34169424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand.
    Bowsher RR; Sailstad JM
    J Pharm Biomed Anal; 2008 Dec; 48(5):1282-9. PubMed ID: 18977625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of assay sensitivity and precision in a malaria antibody ELISA.
    Rajasekariah GH; Kay GE; Russell NV; Smithyman AM
    J Immunoassay Immunochem; 2003; 24(1):89-112. PubMed ID: 12680609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system.
    Berthier F; Lambert C; Genin C; Bienvenu J
    Clin Chem Lab Med; 1999 May; 37(5):593-9. PubMed ID: 10418750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
    Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
    AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
    Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
    J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of performance testing of different rapid diagnostic kits in comparison with EIAs to validate detection of hepatitis B virus among high risk group in Nigeria.
    Afolabi AY; Bakarey AS; Adewumi MO
    J Immunoassay Immunochem; 2018; 39(2):218-227. PubMed ID: 29764292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.
    Chowdhury F; Williams A; Johnson P
    J Immunol Methods; 2009 Jan; 340(1):55-64. PubMed ID: 18983846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing.
    Mora J; Given Chunyk A; Dysinger M; Purushothama S; Ricks C; Osterlund K; Theobald V
    AAPS J; 2014 Nov; 16(6):1175-84. PubMed ID: 25193269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
    Wu Y; Lee JW; Uy L; Abosaleem B; Gunn H; Ma M; DeSilva B
    J Pharm Biomed Anal; 2009 Jul; 49(5):1203-12. PubMed ID: 19356879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
    Jani D; Allinson J; Berisha F; Cowan KJ; Devanarayan V; Gleason C; Jeromin A; Keller S; Khan MU; Nowatzke B; Rhyne P; Stephen L
    AAPS J; 2016 Jan; 18(1):1-14. PubMed ID: 26377333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.